# Nuclide record quantitative-imaging-biomarkers (technology). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/technologies/quantitative-imaging-biomarkers/>
  a schema:MedicalTherapy ;
  nuclide:kind "technology" ;
  schema:identifier "quantitative-imaging-biomarkers" ;
  schema:name "Quantitative imaging biomarkers (RECIST, PERCIST, SUV, ADC)"@en ;
  schema:alternateName "imaging biomarkers"@en, "response criteria"@en, "PERCIST"@en, "standardised uptake value"@en, "apparent diffusion coefficient"@en, "Deauville score"@en, "PI-RADS"@en, "QIBA"@en ;
  schema:description "The numbers pulled from scans that decide whether a cancer is shrinking, growing or dead: tumour diameters for RECIST, sugar uptake on PET, water movement on MRI; they run every trial and most clinic decisions, and they are only as good as the way the scan was taken."@en ;
  schema:url <https://nuclide.cc/technologies/quantitative-imaging-biomarkers/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.ejca.2008.10.026>, <https://www.rsna.org/research/quantitative-imaging-biomarkers-alliance> ;
  nuclide:status "standard-of-care" ;
  nuclide:indications <https://nuclide.cc/indications/prostate/>, <https://nuclide.cc/indications/hcc/> ;
  nuclide:technologies <https://nuclide.cc/technologies/radiomics/>, <https://nuclide.cc/technologies/pet-adapted-therapy/>, <https://nuclide.cc/technologies/fdg-pet/>, <https://nuclide.cc/technologies/ct/>, <https://nuclide.cc/technologies/pet/>, <https://nuclide.cc/technologies/psma-pet/>, <https://nuclide.cc/technologies/fes-pet/> .